| Gina Lee, CNM | |
|
701 Hewitt Blvd, Red Wing, MN 55066-2848 | |
| (651) 267-5000 | |
| Not Available |
| Full Name | Gina Lee |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 5 Years |
| Location | 701 Hewitt Blvd, Red Wing, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174147607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 416 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System In Red Wing | Red wing, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
News Archive
The University of Michigan Medical School will establish a joint institute with the Peking University Health Science Center in a unique effort to promote research that can lead to breakthroughs in pulmonary, cardiovascular and liver diseases.
Believe it or not, a tropical blood parasite native to Latin America could be harmful to Canadians. Infectious diseases like malaria or Zika may have dominated recent headlines but Chagas - the "Kissing Bug" disease - is in the spotlight following the publication of a new case study in the Canadian Medical Association Journal.
Powder processing lies at the heart of pharmaceutical manufacture. It is therefore necessary that efforts to improve efficiency and preserve quality must focus on understanding and controlling powder behaviour.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
› Verified 2 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
The University of Michigan Medical School will establish a joint institute with the Peking University Health Science Center in a unique effort to promote research that can lead to breakthroughs in pulmonary, cardiovascular and liver diseases.
Believe it or not, a tropical blood parasite native to Latin America could be harmful to Canadians. Infectious diseases like malaria or Zika may have dominated recent headlines but Chagas - the "Kissing Bug" disease - is in the spotlight following the publication of a new case study in the Canadian Medical Association Journal.
Powder processing lies at the heart of pharmaceutical manufacture. It is therefore necessary that efforts to improve efficiency and preserve quality must focus on understanding and controlling powder behaviour.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gina Lee, CNM 701 Hewitt Blvd, Red Wing, MN 55066-2848 Ph: () - | Gina Lee, CNM 701 Hewitt Blvd, Red Wing, MN 55066-2848 Ph: (651) 267-5000 |
News Archive
The University of Michigan Medical School will establish a joint institute with the Peking University Health Science Center in a unique effort to promote research that can lead to breakthroughs in pulmonary, cardiovascular and liver diseases.
Believe it or not, a tropical blood parasite native to Latin America could be harmful to Canadians. Infectious diseases like malaria or Zika may have dominated recent headlines but Chagas - the "Kissing Bug" disease - is in the spotlight following the publication of a new case study in the Canadian Medical Association Journal.
Powder processing lies at the heart of pharmaceutical manufacture. It is therefore necessary that efforts to improve efficiency and preserve quality must focus on understanding and controlling powder behaviour.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the European Medicines Agency (EMA) has granted orphan drug designations for sialic acid for the treatment of hereditary inclusion body myopathy (HIBM) and recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type 7.
› Verified 2 days ago
Mrs. April Marie Shuneson, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000 | |
Glenda J Pinkham, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 Hewitt Blvd, Red Wing, MN 55066 Phone: 651-267-5000 |